|
Summary Information: Autolus Therapeutics plc American Depositary Share NASDAQ:AUTL |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Autolus Therapeutics plcis a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
__The following are links to various summary and news pages for __Autolus Therapeutics plc American Depositary Share [ AUTL ]. __Note: Some Links might not have information for the company. |
|